
The Pai lab at UMass Medical School is seeking a postdoctoral candidate in the field of RNA biology and functional genomics with relevant experience in experimental and/or computational biology. Our research combines high-dimensional computational analyses with state-of-the-art genetic, molecular, and cellular genomic techniques to probe the molecular mechanisms of RNA maturation (including transcription, splicing, and 3’ end processing). We specifically focus on characterizing the kinetics of RNA processing steps to understand the overall speed and efficiency at which RNA molecules are created and processed to ensure proper cellular functions.
Ideal applicants will have a strong background in RNA biology, functional genomics, systems biology, or computational biology/bioinformatics. We desire a candidate with both experimental and computational skills, but encourage applications from scientists motivated to expand their skillset to include both approaches. Applicants must be self-motivated, creative, and able to work in a highly collaborative and interdisciplinary environment.
REQUIRED QUALIFICATIONS:
ADDITIONAL DATA:
To apply, please email the following to Athma Pai at athma.pai@umassmed.edu:
This position is in the RNA Therapeutics Institute at the University of Massachusetts Medical School in Worcester, MA. To learn more about the Pai lab, please visit http://www.pai-lab.org.
The RNA Therapeutics Institute is an exceptional training environment, with many interactive and highly collaborative research groups uniting researchers studying fundamental RNA mechanisms with the active development of RNA-based therapeutic strategies. The department has strong intellectual and proximity-based links with neighboring groups in Bioinformatics and Integrative Biology (BIB) and the Program in Systems Biology (PSB) at UMass Medical School, creating a stimulating interdisciplinary research environment with world-class expertise in many disciplines relevant for our work.
UMass Chan Medical School was among 23 companies that stood out as 2023 “DEI champions,” according to The Boston Globe.